Back
OncoCyte Vs. ProPhase Labs Industry Stock Comparison
Sell
45
OCX
OncoCyte
Last Price:
2.70
Seasonality Move:
42.9%
Sell
18
PRPH
ProPhase Labs
Last Price:
0.77
Seasonality Move:
13.45%
Sell
45
OncoCyte (OCX)
is a Sell
Is OncoCyte a Buy, Sell or Hold?
- The current OncoCyte [OCX] share price is $2.71. The Score for OCX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy, Sell or Hold?
- The current ProPhase Labs [PRPH] share price is $0.77. The Score for PRPH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
OCX Stock Price Chart
PRPH Stock Price Chart
What is ProPhase Labs's stock price today?
-
The ProPhase Labs share price today is $0.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight selling pressure.
OCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 41.8 | Sell |
Chaikin Money Flow: | -8651 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.73 - 3.07) | Sell |
Bollinger Bands (100): | (2.89 - 3.21) | Sell |
PRPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 19.19 | Sell |
Chaikin Money Flow: | -29840 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.83 - 2.31) | Sell |
Bollinger Bands (100): | (1.73 - 3.13) | Sell |
OCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.71 | Buy |
20-day SMA: | 2.86 | Sell |
50-day SMA: | 2.97 | Sell |
200-day SMA: | 2.94 | Sell |
8-day EMA: | 2.72 | Sell |
20-day EMA: | 2.82 | Sell |
50-day EMA: | 2.93 | Sell |
200-day EMA: | 3.2 | Sell |
PRPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.77 | Buy |
20-day SMA: | 1.37 | Sell |
50-day SMA: | 1.97 | Sell |
200-day SMA: | 3.81 | Sell |
8-day EMA: | 0.84 | Sell |
20-day EMA: | 1.24 | Sell |
50-day EMA: | 1.83 | Sell |
200-day EMA: | 3.39 | Sell |
OncoCyte Earnings Growth & OCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
ProPhase Labs Earnings Growth & PRPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.
OncoCyte Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProPhase Labs Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |